Significance of Median survival time
Median survival time is a crucial metric used in medical research to evaluate treatment efficacy and patient prognosis. It represents the duration at which half of a group of patients with a particular disease are expected to survive. This measure has been applied in various studies, including those involving tumor-bearing mice, AIDS patients in Malaysia with a median time of 11 months, endometrial cancer patients lasting an average of 70.20 months, and women with pregnancy-associated breast cancer, who exhibited significantly shorter survival compared to control groups.
Synonyms: Average lifespan
The below excerpts are indicatory and do represent direct quotations or translations. It is your responsibility to fact check each reference.
The concept of Median survival time in scientific sources
Median survival time is the central measure of survival durations within a study group, helping evaluate the effectiveness of soy flour and isoflavones treatments against a control group in clinical assessments.
From: The Malaysian Journal of Medical Sciences
(1) This term is a measure of the duration for which the patients lived, and it provides insight into the effectiveness of the treatment in terms of patient survival.[1] (2) This refers to the length of time that half of a group of patients with a disease are expected to live, and it was used to assess the impact of different factors.[2] (3) Median survival time refers to the duration of survival for women with pregnancy-associated breast cancer, which was reported to be significantly shorter than that of the control group in a study.[3] (4) The overall median survival time among AIDS patients in North-East Peninsular Malaysia was revealed to be short, with a recorded time of 11 months.[4] (5) Median survival time is the midpoint at which half the patients have died, significant for understanding the prognosis of HGG patients treated with different methods.[5]